| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Dihydralazine | Dihydralazine EP Impurity A | VE006289 | View CAS 649765-80-0 |
Dihydralazine Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Dihydralazine | Dihydralazine EP Impurity A | VE006289 | View CAS 649765-80-0 |
| Catalogue No. | VE006289 |
| CAS No. | 649765-80-0 |
| Molecular Formula | C8H9N5 |
| Molecular Weight | 175.19 g/mol |
| Parent drug | Dihydralazine |
| IUPAC Name | 4-Hydrazinophthalazin-1-amine |
| Synonyms | N/A |
| References | Gumieniczek, Anna, et al. “Kinetics and Characterization of Degradation Products of Dihydralazine and Hydrochlorothiazide in Binary Mixture by HPLC-UV, LC-DAD and LC–MS Methods.” Chromatographia, vol. 81, no. 8, June 2018, pp. 1147–62, https://doi.org/10.1007/s10337-018-3555-8.?Wacker, Juergen R., et al. “Antihypertensive Therapy in Patients with Pre-Eclampsia: A Prospective Randomised Multicentre Study Comparing Dihydralazine with Urapidil.” European Journal of Obstetrics & Gynecology and Reprod |
| Status | In-stock |
| ListName | Dihydralazine EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
